Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: dermal

Currently viewing:

Administrative data

Endpoint:
acute toxicity: dermal
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2022

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 402 (Acute Dermal Toxicity: Fixed Dose Procedure)
GLP compliance:
yes
Test type:
fixed dose procedure
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
-
EC Number:
421-450-8
EC Name:
-
Cas Number:
154702-15-5
Molecular formula:
C44H59N7O5
IUPAC Name:
2-ethylhexyl 4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoate

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
female

Administration / exposure

Type of coverage:
occlusive
Vehicle:
unchanged (no vehicle)
Duration of exposure:
24 h
Doses:
2000 mg/kg
No. of animals per sex per dose:
2

Results and discussion

Preliminary study:
A total of 3 female SD rats were used dermally exposed to test item for 24h which was moistened by 1.0 mL ultrapure water in the range-finding study, with 1 rat in each step exposed to the dosage of 200, 1000 and 2000 mg/kg, respectively.
Effect levels
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Mortality:
0
Clinical signs:
other: none of the above
Body weight:
lower than 10% body weight loss
Remarks:
Compared with its own body weight on D0, the body weight of the rats (ID: 6033, 6034) decreased 1.70%, 3.39% on D7, and increased 5.46%, 6.97% on D14, compared with its own body weight on D0.
Gross pathology:
No treatment- related abnormal viscera lesions were observed after exposure.
Other findings:
The mean score of 6033 and 6034 got 0.33,0.33 for erythema/eschar, got 0.00, 0.00 for oedema.

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
No mortality was observed in all rats at dose of 2000 mg/kg. Herein the acute dermal LD5 0 of Diethylhexyl Butamido Triazone in SD rats >2000 mg/kg.